: Evaluation of the early effect of drugs in patients with neurological damage
Phase 3
- Conditions
- eurological damage caused by brain trauma.Other disorders of nervous systemG98.8
- Registration Number
- IRCT20170105031787N5
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients over 12 years
Patients with neurological damage caused by brain trauma on radiograph or electroencephalogram with a GCS score of less than 9
Exclusion Criteria
Patients over 60 years
Patients with fractures of other body parts
Patients with fractures of other organs and other problems requiring surgical intervention, such as internal bleeding, rupture of internal organs, severe chest trauma in the medical record or radiographic view.
Patients with spinal cord trauma
Suffering from a dangerous trauma other than head trauma, including internal bleeding, systolic blood pressure drop less than 80 mmHg, and chest trauma within the first 24 hours.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evel of consciousness. Timepoint: Before the intervention and 1 week after the intervention. Method of measurement: Glasgow coma criteria.;Deep venous thrombosis of the lower limb. Timepoint: After intervention. Method of measurement: Based on ultrasound.;Frequency of deaths. Timepoint: After intervention. Method of measurement: Based on the information in the patient's record.
- Secondary Outcome Measures
Name Time Method